Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietmar Seiffert

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Pharmacology|May 30, 2015
In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonistBrian E Hawes, Ying Zhai, David Hesk, et al.
Thrombosis Research|February 20, 2003
Regulation of clot retraction by glycoprotein IIb/IIIa antagonistsDietmar Seiffert, Donna L Pedicord, Cathy J Kieras, et al.
Biochemical and Biophysical Research Communications|December 10, 2002
Gamma-secretase activity is not involved in presenilin-mediated regulation of beta-cateninJere E Meredith, Qian Wang, Thomas J Mitchell, et al.
Thrombosis and Haemostasis|March 9, 2012
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher traitJ Eileen Bird, Patricia L Smith, Xinkang Wang, et al.
Journal of Immunological Methods|July 5, 2005
Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexesLeah Breth, Jennifer Kochie, Amanda Combs, et al.
Scientific Reports|December 23, 2022
Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitorVidya Perera, Zhaoqing Wang, Susan Lubin, et al.
Cardiology and Therapy|May 31, 2022
Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa InhibitorVidya Perera, Zhaoqing Wang, Susan Lubin, et al.
Thrombosis Research|May 16, 2008
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasisJ Eileen Bird, Mary R Giancarli, Nick Allegretto, et al.
Scientific Reports|March 26, 2022
Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participantsVidya Perera, Zhaoqing Wang, Susan Lubin, et al.
Thrombosis Research|September 29, 2015
Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion modelVinay Bhal, Michael J Herr, Mason Dixon, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Pharmacology|May 30, 2015
In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonistBrian E Hawes, Ying Zhai, David Hesk, et al.
Thrombosis Research|February 20, 2003
Regulation of clot retraction by glycoprotein IIb/IIIa antagonistsDietmar Seiffert, Donna L Pedicord, Cathy J Kieras, et al.
Biochemical and Biophysical Research Communications|December 10, 2002
Gamma-secretase activity is not involved in presenilin-mediated regulation of beta-cateninJere E Meredith, Qian Wang, Thomas J Mitchell, et al.
Thrombosis and Haemostasis|March 9, 2012
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher traitJ Eileen Bird, Patricia L Smith, Xinkang Wang, et al.
Journal of Immunological Methods|July 5, 2005
Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexesLeah Breth, Jennifer Kochie, Amanda Combs, et al.
Scientific Reports|December 23, 2022
Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitorVidya Perera, Zhaoqing Wang, Susan Lubin, et al.
Cardiology and Therapy|May 31, 2022
Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa InhibitorVidya Perera, Zhaoqing Wang, Susan Lubin, et al.
Thrombosis Research|May 16, 2008
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasisJ Eileen Bird, Mary R Giancarli, Nick Allegretto, et al.
Scientific Reports|March 26, 2022
Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participantsVidya Perera, Zhaoqing Wang, Susan Lubin, et al.
Thrombosis Research|September 29, 2015
Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion modelVinay Bhal, Michael J Herr, Mason Dixon, et al.
Pageof 5